ALPHA TEKNOVA, INC. Increase (Decrease) in Accounts Receivable
ALPHA TEKNOVA, INC. (TKNO) reported Increase (Decrease) in Accounts Receivable of $795.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$266.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $1.06M, a 21.35% decline year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$520.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $17.00K, a 30.77% increase year-over-year.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for fiscal 2025 was $374.00K, a 24.29% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for fiscal 2024 was $494.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$292.00K.
- ALPHA TEKNOVA, INC. increase (decrease) in accounts receivable for fiscal 2022 was -$380.00K, a 236.69% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$266.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $795.00K 10-Q · filed 2026-08-06 | $275.00K derived: sum of 3 quarters · filed 2026-08-06 | $292.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-07 | $541.00K derived: sum of 2 quarters · filed 2026-05-07 | $558.00K derived: sum of 3 quarters · filed 2026-05-07 | $86.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$520.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$503.00K derived: sum of 2 quarters · filed 2026-03-02 | -$975.00K derived: sum of 3 quarters · filed 2026-08-06 | $374.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$455.00K derived: sum of 2 quarters · filed 2026-08-06 | $894.00K 10-Q · filed 2025-11-07 | $670.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $877.00K 10-Q · filed 2026-08-06 | $653.00K derived: sum of 3 quarters · filed 2026-08-06 | $666.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.35M 10-Q · filed 2026-05-07 | $1.13M derived: sum of 2 quarters · filed 2026-05-07 | $1.14M derived: sum of 3 quarters · filed 2026-05-07 | $1.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$224.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$211.00K derived: sum of 2 quarters · filed 2026-03-02 | -$125.00K derived: sum of 3 quarters · filed 2026-03-02 | $494.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $99.00K derived: sum of 2 quarters · filed 2025-11-07 | $718.00K 10-Q · filed 2025-11-07 | -$295.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $705.00K 10-Q · filed 2025-08-08 | -$308.00K derived: sum of 3 quarters · filed 2025-08-08 | $94.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $619.00K 10-Q · filed 2025-05-09 | -$394.00K derived: sum of 2 quarters · filed 2025-05-09 | $8.00K derived: sum of 3 quarters · filed 2025-05-09 | -$191.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$611.00K derived: sum of 2 quarters · filed 2025-03-07 | -$810.00K derived: sum of 3 quarters · filed 2025-03-07 | -$292.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | $402.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $203.00K derived: sum of 2 quarters · filed 2024-11-08 | $721.00K 10-Q · filed 2024-11-08 | -$608.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $319.00K 10-Q · filed 2024-08-13 | -$1.01M derived: sum of 3 quarters · filed 2024-08-13 | -$1.24M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $518.00K 10-Q · filed 2024-05-13 | -$811.00K derived: sum of 2 quarters · filed 2024-05-13 | -$1.04M derived: sum of 3 quarters · filed 2024-05-13 | -$1.18M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | -$1.56M derived: sum of 2 quarters · filed 2024-03-27 | -$1.70M derived: sum of 3 quarters · filed 2024-03-27 | -$380.00K 10-K · filed 2024-03-27 |
| 2022-09-30 | -$227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$370.00K derived: sum of 2 quarters · filed 2023-11-13 | $949.00K 10-Q · filed 2023-11-13 | $1.06M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.18M 10-Q · filed 2023-08-11 | $1.28M derived: sum of 3 quarters · filed 2023-08-11 | $1.79M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $1.32M 10-Q · filed 2023-05-11 | $1.43M derived: sum of 2 quarters · filed 2023-05-11 | $1.93M derived: sum of 3 quarters · filed 2023-05-11 | $1.20M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $612.00K derived: sum of 2 quarters · filed 2023-03-30 | -$122.00K derived: sum of 3 quarters · filed 2023-03-30 | $278.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $504.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$230.00K derived: sum of 2 quarters · filed 2022-11-14 | $170.00K 10-Q · filed 2022-11-14 | $51.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$734.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$334.00K 10-Q · filed 2022-08-11 | -$453.00K derived: sum of 3 quarters · filed 2022-08-11 | $1.48M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-12 | $281.00K derived: sum of 2 quarters · filed 2022-05-12 | $2.21M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | -$119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $1.81M derived: sum of 2 quarters · filed 2022-03-18 | $2.35M 10-K · filed 2022-03-18 | |
| 2020-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $2.47M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | $542.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |